Sep. 2 at 10:02 PM
$RCKT btw Rocket still has other outstanding warrants that are not RCKTW and have longer (or no fixed) expiries.
From the June 30, 2026 summary:
•
$57.11 exercise price — expire Dec 21, 2030 (~603k)
•
$33.63 — expire Aug 9, 2031 (~301k)
•
$22.51 — expire Dec 17, 2031 (two tranches totaling ~306k)
•
$0.01 pre-funded warrants — no expiration (~3.5M total from 2023/2024 issuances to RTW-affiliated funds).
The expiry today of the Renovacor warrants corresponded to 760,086 shares of Rocket Pharmaceuticals common stock (at
$65.23 ex). Hopefully no one here was suckered in to buy them only to find they just expired.
Let's hope this housekeeping continues - like the Employee equity change-of-control filing last week, it all points to nice clean books that are acquisition-ready.
